Base Year
Historical Year
Forecast Year
The United States vaccine market attained a value of about USD 14.82 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 9.8%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The initiation of vaccine development through mRNA technology is increasing research and development (R&D) activities owing to the prevalence of various infectious diseases, such as Ebola, Zika, and influenza, among others. This trend has been fuelled due to the emergence of SARS-CoV-2, which is surging the requirement for effective vaccines to prevent morbidity and fatality, which has driven the market.
As research activities to develop efficient vaccines were initiated, mRNA technology was leveraged to easily modify the sequencing of vaccines to enable their effectiveness against the mutations of the novel virus, which has driven the market growth. Moreover, the development of mRNA vaccines against COVID-19 infections by leading companies, such as Pfizer and Moderna, has fuelled the market growth. The increasing approvals of the novel COVID-19 mRNA vaccines have provided further impetus to the market growth. For instance, the Food and Drug Administration of the United States authorised the emergency use of Pfizer’s mRNA vaccine, BNT162b2, in December 2020.
A vaccine is a medicine that enables the suspension of killed or weakened microbes to enable the development of antibodies and prevent the risk of contraction of infectious disease. It provides active immunity from diseases to enhance the quality of life. The administration of vaccines, variously known as vaccination, is one of the most effective ways to prevent the spread of infectious diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major technologies of vaccine are:
The market can be broadly categorised on the basis of its indications into:
By end uses, the market is divided into:
The EMR report looks into the regional markets of vaccine in the United States like New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rising demand for vaccines of pathogenic issues, diarrhoeal diseases, and parasitic adversaries, among others, is augmenting the industry growth. As the requirement of immunisation of infants to enhance the quality of life is surging, vaccines are increasingly deployed to prevent the risk of infectious diseases among children, hence fuelling the market growth. For instance, federally funded programs such as the Vaccines for Children (VFC) and Children’s Health Insurance Program (CHIP) offers free vaccination for underprivileged children. Moreover, the deployment of cutting-edge technologies to enable the swift development of vaccines is propelling the market growth.
The development of innovative vaccines that can be delivered through micro patches to enable efficient vaccination in infants is anticipated to augment the market growth. Advancements in biotechnology and genetic engineering are expected to lead to the determination of accurate structures of antigens, hence aiding in the development of more efficient vaccines. In addition, the increasing concerns regarding the resurgence of COVID-19 infections and the emergence of a novel virus are projected to propel the growth of the vaccine industry in the forecast period.
The report presents a detailed analysis of the following key players in the United States vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Indication |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
United States Vaccine Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the United States vaccine market attained a value of nearly USD 14.82 billion.
The market is projected to grow at a CAGR of 9.8% between 2024 and 2032.
The market is being aided by the rising use of mRNA technology in vaccine development, the surge of the COVID-19 crisis, and the increasing approvals of the novel COVID-19 mRNA vaccines.
The industry is expected to be augmented by the rising demand for immunisation of infants, the deployment of cutting-edge technology in vaccine development, and advancements in biotechnology and genetic engineering.
The major regions in the industry are New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
The major technologies of vaccine in the industry are recombinant and conjugate vaccine, inactivated vaccines, live attenuated vaccines, and toxoid vaccines, among others.
The significant indications in the market are pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella, measles, mumps, and rubella, diphtheria, pertussis, and tetanus (DPT), polio, and hepatitis, among others.
The various end uses of vaccines are paediatric vaccine, adult vaccine, and travellers vaccine.
The major players in the industry are GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, AstraZeneca plc, and Johnson & Johnson Services, Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share